The COVID-19 pandemic, the re-emergence of specific pathogens and antimicrobial resistance (AMR) underline the critical importance of infectious disease research. Furthermore, ~18% of all human cancers are caused by infectious agents and effective vaccines exist against only some of these pathogens. Recent advances in our understanding of immune checkpoints have been critical for the development of improved cancer treatments. However, we still lack a basic understanding of the correlates of immune protection, the nature of the innate immune responses involved, and the interactions between the innate/adaptive immune systems. There is a need to understand these factors in chronic infections, in which the trade-off between beneficial and harmful effects of inflammation and immunity can differ fundamentally from acute, transient infections. The Immuno-Pathology Network will interact with the Imperial Network for Vaccine Research and Antimicrobial Research Collaborative to investigate these important issues.

Members

Dr Maddalena Cerrone

Dr Maddalena Cerrone
Clinical Research Fellow

Phebe Ekregbesi

Phebe Ekregbesi
Laboratory Research Technician

Professor Brian Gazzard

Professor Brian Gazzard

Dr Catherine Kibirige

Dr Catherine Kibirige
Research Associate

Dr Maria-Cristina Loader

Dr Maria-Cristina Loader
Clinical Research Fellow

Dr Claudia Selck

Dr Claudia Selck